Genomic and phenotypic characterization of experimentally selected resistant **Leishmania donovani** reveals a role for dynamin-1-like protein in the mechanism of resistance to a novel antileishmanial compound

Source
mBio - ISSN 2150-7511-13:1 (2022) p.
Author(s)

Nanobody-aided crystallization of the transcription regulator PaaR2 from Escherichia coli O157:H7

Source
Acta Chrystallographica Section F - ISSN 2053-230X-77:10 (2021) p. 374-384
Author(s)
    Pieter De Bruyn, Maruša Prolič-Kalinšek, Alexandra Vandervelde, Milan Malfait, Yann Sterckx, Frank Sobott, San Hadži, Els Pardon, Jan Steyaert, Remy Loris

The history of anti-trypanosome vaccine development shows that highly immunogenic and exposed pathogen-derived antigens are not necessarily good target candidates : enolase and ISG75 as examples

Source
Pathogens - ISSN 2076-0817-10:8 (2021) p.
Author(s)

Immunogenicity risk profile of nanobodies

Source
Frontiers in immunology - ISSN 1664-3224-12 (2021) p.
Author(s)
    Chloé Ackaert, Natalia Smiejkowska, Catarina Xavier, Yann Sterckx, Sofie Denies, Benoit Stijlemans, Yvon Elkrim, Nick Devoogdt, Vicky Caveliers, Tony Lahoutte, Serge Muyldermans, Karine Breckpot, Marleen Keyaerts

Lateral flow assays are essential tools in the battle against infectious diseases and are crucial in the long-term control of sleeping sickness

Source
Challenges in disease and health research / Nozic, Darko [edit.]; et al. [edit.]-p. 48-68
Author(s)